0001654824-17-000001.txt : 20170605
0001654824-17-000001.hdr.sgml : 20170605
20170605183526
ACCESSION NUMBER: 0001654824-17-000001
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170601
FILED AS OF DATE: 20170605
DATE AS OF CHANGE: 20170605
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Evolent Health, Inc.
CENTRAL INDEX KEY: 0001628908
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT SERVICES [8741]
IRS NUMBER: 320454912
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 800 NORTH GLEBE RD, SUITE 500
CITY: ARLINGTON
STATE: VA
ZIP: 22203
BUSINESS PHONE: 571-389-6000
MAIL ADDRESS:
STREET 1: 800 NORTH GLEBE RD, SUITE 500
CITY: ARLINGTON
STATE: VA
ZIP: 22203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stone Lydia
CENTRAL INDEX KEY: 0001654824
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37415
FILM NUMBER: 17892582
MAIL ADDRESS:
STREET 1: 800 N. GLEBE ROAD, SUITE 500
CITY: ARLINGTON
STATE: VA
ZIP: 22203
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2017-06-01
0
0001628908
Evolent Health, Inc.
EVH
0001654824
Stone Lydia
C/O EVOLENT HEALTH, INC.
800 N. GLEBE ROAD, SUITE 500
ARLINGTON
VA
22203
0
1
0
0
Principal Accounting Officer
Class A Common Stock
2017-06-01
4
S
0
887
22.95
D
9587
D
Class A Common Stock
2017-06-01
4
M
0
1000
6.87
A
10587
D
Class A Common Stock
2017-06-01
4
S
0
1000
23.04
D
9587
D
Class A Common Stock
2017-06-01
4
M
0
2908
10.27
A
12495
D
Class A Common Stock
2017-06-01
4
S
0
2908
22.87
D
9587
D
Class A Common Stock Option (right to buy)
6.87
2017-06-01
4
M
0
1000
0
D
2025-01-01
Class A Common Stock
1000
2000
D
Class A Common Stock Option (right to buy)
10.27
2017-06-01
4
M
0
2908
0
D
2026-03-01
Class A Common Stock
2908
8722
D
Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $22.75-23.00, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate prices within the range set forth in this footnote.
The Class A Common Stock Options exercised vested on January 1, 2017.
The Class A Common Stock Options exercised vested on March 1, 2017.
/s/ Jonathan Weinberg, Attorney-in-fact
2017-06-05